{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:06:31Z","timestamp":1791281191150,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s10157-010-0401-1","type":"journal-article","created":{"date-parts":[[2011,1,21]],"date-time":"2011-01-21T09:27:53Z","timestamp":1295602073000},"page":"410-413","source":"Crossref","is-referenced-by-count":1,"title":["Nephrotic syndrome developing during induction chemotherapy for childhood acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"15","author":[{"given":"Chanel","family":"Prestidge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrad Rod","family":"Rassekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas G.","family":"Matsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,1]]},"reference":[{"issue":"147\u20138","key":"401_CR1","first-page":"53","volume":"76","author":"S Papper","year":"1984","unstructured":"Papper S. Nephrotic syndrome and neoplasm. The findings to date, with practical implications. Postgrad Med. 1984;76(147\u20138):53\u20138.","journal-title":"Postgrad Med"},{"key":"401_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0002-9343(86)90049-5","volume":"80","author":"DJ Dabbs","year":"1986","unstructured":"Dabbs DJ, Striker LM, Mignon F, Striker G. Glomerular lesions in lymphomas and leukemias. Am J Med. 1986;80:63\u201370.","journal-title":"Am J Med"},{"key":"401_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1046\/j.1523-1755.1999.00548.x","volume":"56","author":"PM Ronco","year":"1999","unstructured":"Ronco PM. Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int. 1999;56:355\u201377.","journal-title":"Kidney Int"},{"key":"401_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00467-007-0703-z","volume":"23","author":"R Sinha","year":"2008","unstructured":"Sinha R, AlAbbas A, Dionne JM, Hurley RM. Simultaneous occurrence of atypical hemolytic uremic syndrome and acute lymphoblastic leukemia: a case report and literature review. Pediatr Nephrol. 2008;23:835\u20139.","journal-title":"Pediatr Nephrol"},{"key":"401_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.7326\/0003-4819-64-1-41","volume":"64","author":"JC Lee","year":"1966","unstructured":"Lee JC, Yamauchi H, Hopper J Jr. The association of cancer and the nephrotic syndrome. Ann Intern Med. 1966;64:41\u201351.","journal-title":"Ann Intern Med"},{"key":"401_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1034\/j.1600-0609.2001.5790493.x","volume":"67","author":"N Da\u2019as","year":"2001","unstructured":"Da\u2019as N, Polliack A, Cohen Y, Amir G, Darmon D, Kleinman Y, et al. Kidney involvement and renal manifestations in non-Hodgkin\u2019s lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur J Haematol. 2001;67:158\u201364.","journal-title":"Eur J Haematol"},{"key":"401_CR7","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1007\/s00467-004-1591-0","volume":"19","author":"M Bhatia","year":"2004","unstructured":"Bhatia M, Kher K, Minniti CP. Acute lymphoblastic leukemia in a child with nephrotic syndrome. Pediatr Nephrol. 2004;19:1290\u20133.","journal-title":"Pediatr Nephrol"},{"key":"401_CR8","first-page":"91","volume":"31","author":"W Kuis","year":"1976","unstructured":"Kuis W, de Kraker J, Kuijten RH, Donckerwolcke RA, Voute PA. Acute lymphoblastic leukaemia after treatment of nephrotic syndrome with immunosuppressive drugs. Helv Paediatr Acta. 1976;31:91\u20135.","journal-title":"Helv Paediatr Acta"},{"key":"401_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/BF00856558","volume":"8","author":"FE Mackie","year":"1994","unstructured":"Mackie FE, Roy LP, Stevens M. Onset of leukaemia after levamisole treatment for nephrotic syndrome. Pediatr Nephrol. 1994;8:527\u20138.","journal-title":"Pediatr Nephrol"},{"key":"401_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/BF00441722","volume":"136","author":"W Muller","year":"1981","unstructured":"Muller W, Brandis M. Acute leukemia after cytotoxic treatment for nonmalignant disease in childhood. Eur J Pediatr. 1981;136:105\u20138.","journal-title":"Eur J Pediatr"},{"key":"401_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s002770050583","volume":"79","author":"L Perard","year":"2000","unstructured":"Perard L, Thomas X, Jaumain H, Theuil G, Bret M, Coronel B, et al. T-cell lineage acute lymphoblastic leukemia with chromosome 5 abnormality in a patient with Crohn\u2019s disease and lipoid nephrosis. Ann Hematol. 2000;79:222\u20135.","journal-title":"Ann Hematol"},{"key":"401_CR12","first-page":"231","volume":"10","author":"D Rajpoot","year":"1990","unstructured":"Rajpoot D, Tejani A, Rao S, Miller S. Focal segmental glomerulosclerosis in a child with acute lymphoblastic leukemia. Child Nephrol Urol. 1990;10:231\u20133.","journal-title":"Child Nephrol Urol"},{"key":"401_CR13","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/00043426-199809000-00015","volume":"20","author":"RK Sathiapalan","year":"1998","unstructured":"Sathiapalan RK, Velez MC, McWhorter ME, Irwin K, Correa H, Baliga R, et al. Focal segmental glomerulosclerosis in children with acute lymphocytic leukemia: case reports and review of literature. J Pediatr Hematol Oncol. 1998;20:482\u20135.","journal-title":"J Pediatr Hematol Oncol"},{"key":"401_CR14","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/ki.1991.293","volume":"40","author":"RT Fiser","year":"1991","unstructured":"Fiser RT, Arnold WC, Charlton RK, Steele RW, Childress SH, Shirkey B. T-lymphocyte subsets in nephrotic syndrome. Kidney Int. 1991;40:913\u20136.","journal-title":"Kidney Int"},{"key":"401_CR15","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","volume":"2","author":"RJ Shalhoub","year":"1974","unstructured":"Shalhoub RJ. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet. 1974;2:556\u201360.","journal-title":"Lancet"},{"key":"401_CR16","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s004679900269","volume":"14","author":"EH Garin","year":"2000","unstructured":"Garin EH. Circulating mediators of proteinuria in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol. 2000;14:872\u20138.","journal-title":"Pediatr Nephrol"},{"key":"401_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/BF00858545","volume":"3","author":"WW Bakker","year":"1989","unstructured":"Bakker WW, van Luijk WH. Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome? Pediatr Nephrol. 1989;3:341\u20139.","journal-title":"Pediatr Nephrol"},{"key":"401_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/ndt\/gfn459","volume":"24","author":"E Gonzalez","year":"2009","unstructured":"Gonzalez E, Neuhaus T, Kemper MJ, Girardin E. Proteomic analysis of mononuclear cells of patients with minimal-change nephrotic syndrome of childhood. Nephrol Dial Transplant. 2009;24:149\u201355.","journal-title":"Nephrol Dial Transplant"},{"key":"401_CR19","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1681\/ASN.V1351238","volume":"13","author":"D Sahali","year":"2002","unstructured":"Sahali D, Pawlak A, Valanciute A, Grimbert P, Lang P, Remy P, et al. A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening. J Am Soc Nephrol. 2002;13:1238\u201347.","journal-title":"J Am Soc Nephrol"},{"key":"401_CR20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/cyto.990140212","volume":"14","author":"LE Hultin","year":"1993","unstructured":"Hultin LE, Hausner MA, Hultin PM, Giorgi JV. CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes. Cytometry. 1993;14:196\u2013204.","journal-title":"Cytometry"},{"key":"401_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3324\/haematol.10564","volume":"92","author":"A Kolstad","year":"2007","unstructured":"Kolstad A, Holte H, Fossa A, Lauritzsen GF, Gaustad P, Torfoss D. Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen. Haematologica. 2007;92:139\u201340.","journal-title":"Haematologica"},{"key":"401_CR22","first-page":"1006","volume":"4","author":"DG Motto","year":"2002","unstructured":"Motto DG, Williams JA, Boxer LA. Rituximab for refractory childhood autoimmune hemolytic anemia. Isr Med Assoc J. 2002;4:1006\u20138.","journal-title":"Isr Med Assoc J"},{"key":"401_CR23","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1681\/ASN.V1281648","volume":"12","author":"D Sahali","year":"2001","unstructured":"Sahali D, Pawlak A, Le Gouvello S, Lang P, Valanciute A, Remy P, et al. Transcriptional and post-transcriptional alterations of IkappaBalpha in active minimal-change nephrotic syndrome. J Am Soc Nephrol. 2001;12:1648\u201358.","journal-title":"J Am Soc Nephrol"},{"key":"401_CR24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.264.65.1","volume":"65","author":"AR Jazirehi","year":"2005","unstructured":"Jazirehi AR, Huerta-Yepez S, Cheng G, Bonavida B. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin\u2019s lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis. Cancer Res. 2005;65:264\u201376.","journal-title":"Cancer Res"},{"key":"401_CR25","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1053\/j.ajkd.2007.06.021","volume":"50","author":"N Aggarwal","year":"2007","unstructured":"Aggarwal N, Batwara R, McCarthy ET, Sharma R, Sharma M, Savin VJ. Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease. Am J Kidney Dis. 2007;50:826\u20139.","journal-title":"Am J Kidney Dis"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-010-0401-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-010-0401-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-010-0401-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-010-0401-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T23:02:59Z","timestamp":1685919779000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-010-0401-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["401"],"URL":"https:\/\/doi.org\/10.1007\/s10157-010-0401-1","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}